Project description
Innovative treatment of cardiac arrhythmia
Atrial fibrillation (AF) is an irregular and rapid heart rhythm associated with blood clots in the heart. Treatment usually involves the prescription of medication to control heart rate or anticoagulants to prevent blood clots. Catheter ablation is a procedure used in certain cases of AF to destroy the diseased tissue. Funded by the European Innovation Council, the DMUT project aims to develop a contactless approach for tissue ablation. The proposed technology delivers ultrasonic energy through a miniature-transcatheter ultrasound-based approach. Importantly, it combines signal and image processing for real-time tissue monitoring. The activities of the DMUT project cover the transition from preclinical to clinical studies as well as efficacy and safety validation.
Objective
Our mission is to radically change the landscape of cardiac ablation. Our products, based on proprietary ultrasound technology, allow contactless tissue ablation with real-time lesion monitoring, bringing Healium to the forefront of the cardiac ablation market. Our team, backed by scientific and business advisors, includes Dr. Eckhouse, Chairman, leading medical entrepreneur who has founded >20 companies, and cumulated >€1B in exits (Ventor for $325M, Synron and Lumenis both IPO > $1B). Ran Sela, CEO and co-founder, >15 years of medical device development and project management. Dr. Megel, CTO, and co-founder, >25 years in ultrasound-based medical devices. Now, we are at the top-risk phase of our development journey: the transition from preclinical to clinical studies. Leveraging an EC investment of €12.75M we can demonstrate the efficacy and safety of our product, establish a manufacturing line and regulatory framework, and access the market as a self-sustained company.
Fields of science
Programme(s)
Funding Scheme
HORIZON-AG - HORIZON Action Grant Budget-BasedCoordinator
2069202 YOKNEAM
Israel
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.